{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T15:05:02Z","timestamp":1770044702986,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T00:00:00Z","timestamp":1475625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T00:00:00Z","timestamp":1475625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Triterpenoid Toosendanin (TSN) exhibits a plenty of pharmacological effects in human and great values in agriculture. However, the hepatotoxicity caused by TSN or Melia-family plants containing TSN used in traditional Chinese medicine has been reported and the mechanisms of TSN-induced liver injury (TILI) still remain largely unknown. In this study, the dose- and time-dependent effects of TSN on mice liver were investigated by an integrated microRNA-mRNA approach as well as the general toxicological assessments. As the results, the dose- and time-dependent liver injury and alterations in global microRNA and mRNA expressions were detected. Particularly, 9-days 80\u2009mg\/kg TSN exposure caused most serious liver injury in mice and the hepatic adaptation to TILI was unexpectedly observed after 21-days 80\u2009mg\/kg TSN administration. Based on the pathway analysis of the intersections between predicted targets of differentially expressed microRNAs and differentially expressed mRNAs at three time points, it revealed that TILI may be caused by glutathione depletion, mitochondrial dysfunction and lipid dysmetabolism, ultimately leading to hepatocytes necrosis in liver, while liver regeneration may play an important role in the hepatic adaptation to TILI. Our results demonstrated that the integrated microRNA\u2212mRNA approach could provide new insight into the complex and dynamic behavior of TILI.<\/jats:p>","DOI":"10.1038\/srep34225","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T09:49:16Z","timestamp":1475660956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Integrated analysis of microRNA and mRNA expression profiles highlights the complex and dynamic behavior of toosendanin-induced liver injury in mice"],"prefix":"10.1038","volume":"6","author":[{"given":"Xiaoyan","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueping","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,5]]},"reference":[{"key":"BFsrep34225_CR1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","volume":"89","author":"MD Leise","year":"2014","unstructured":"Leise, M. D., Poterucha, J. J. & Talwalkar, J. A. Drug-induced liver injury. Mayo Clin. Proc. 89, 95\u2013106 (2014).","journal-title":"Mayo Clin. Proc."},{"key":"BFsrep34225_CR2","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","volume":"135","author":"N Chalasani","year":"2008","unstructured":"Chalasani, N. et al. Causes, clinical features and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135, 1924\u20131934, 1934 e1-4 (2008).","journal-title":"Gastroenterology"},{"key":"BFsrep34225_CR3","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ajg.2012.138","volume":"107","author":"KT Suk","year":"2012","unstructured":"Suk, K. T. et al. A prospective nationwide study of drug-induced liver injury in Korea. Am. J. Gastroenterol. 107, 1380\u20131387 (2012).","journal-title":"Am. J. Gastroenterol."},{"key":"BFsrep34225_CR4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/MEG.0b013e32835f6889","volume":"25","author":"Y Zhou","year":"2013","unstructured":"Zhou, Y., Yang, L., Liao, Z., He, X. & Guo, H. Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients. Eur. J. Gastroenterol. Hepatol. 25, 825\u2013829 (2013).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFsrep34225_CR5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/cld.386","volume":"4","author":"GQ Wang","year":"2014","unstructured":"Wang, G. Q., Deng, Y. Q. & Hou, F. Q. Overview of Drug-Induced Liver Injury in China. Clin. Liver Dis. 4, 26\u201329 (2014).","journal-title":"Clin. Liver Dis."},{"key":"BFsrep34225_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2007.02.002","volume":"82","author":"YL Shi","year":"2007","unstructured":"Shi, Y. L. & Li, M. F. Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine. Prog. Neurobiol. 82, 1\u201310 (2007).","journal-title":"Prog. Neurobiol."},{"key":"BFsrep34225_CR7","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1055\/s-0029-1240902","volume":"76","author":"Y He","year":"2010","unstructured":"He, Y. et al. Toosendanin inhibits hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis. Planta Med. 76, 1447\u20131453 (2010).","journal-title":"Planta Med."},{"key":"BFsrep34225_CR8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10637-005-0909-5","volume":"23","author":"B Zhang","year":"2005","unstructured":"Zhang, B., Wang, Z. F., Tang, M. Z. & Shi, Y. L. Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from chinese traditional medicine. Invest. New Drugs 23, 547\u2013553 (2005).","journal-title":"Invest. New Drugs"},{"key":"BFsrep34225_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2004.03.023","volume":"201","author":"MZ Tang","year":"2004","unstructured":"Tang, M. Z., Wang, Z. F. & Shi, Y. L. Involvement of cytochrome c release and caspase activation in toosendanin-induced PC12 cell apoptosis. Toxicology 201, 31\u201338 (2004).","journal-title":"Toxicology"},{"key":"BFsrep34225_CR10","doi-asserted-by":"crossref","first-page":"e52536","DOI":"10.1371\/journal.pone.0052536","volume":"7","author":"J Ju","year":"2012","unstructured":"Ju, J. et al. The apoptotic effects of toosendanin are partially mediated by activation of deoxycytidine kinase in HL-60 cells. PLoS One 7, e52536 (2012).","journal-title":"PLoS One"},{"key":"BFsrep34225_CR11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.tiv.2012.09.013","volume":"27","author":"J Ju","year":"2013","unstructured":"Ju, J. et al. Toosendanin induces apoptosis through suppression of JNK signaling pathway in HL-60 cells. Toxicol. In Vitro 27, 232\u2013238 (2013).","journal-title":"Toxicol. In Vitro"},{"key":"BFsrep34225_CR12","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1128\/AAC.01780-10","volume":"55","author":"T Watanabe","year":"2011","unstructured":"Watanabe, T. et al. Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection. Antimicrob. Agents Chemother. 55, 2537\u20132545 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFsrep34225_CR13","first-page":"2045","volume":"33","author":"SY Qi","year":"2008","unstructured":"Qi, S. Y., Jin, R. M., Liu, H. J. & Huang, Y. W. Mechanism studies on hepatotoxicity of rats induced by fructus toosendan. Zhongguo Zhong Yao Za Zhi 33, 2045\u20132047 Chinese (2008).","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"BFsrep34225_CR14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tox.2008.04.005","volume":"249","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Roles of reactive oxygen species and MAP kinases in the primary rat hepatocytes death induced by toosendanin. Toxicology 249, 62\u201368 (2008).","journal-title":"Toxicology"},{"key":"BFsrep34225_CR15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","volume":"79","author":"MR Fabian","year":"2010","unstructured":"Fabian, M. R., Sonenberg, N. & Filipowicz, W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351\u2013379 (2010).","journal-title":"Annu. Rev. Biochem."},{"key":"BFsrep34225_CR16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman, R. C., Farh, K. K., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92\u2013105 (2009).","journal-title":"Genome Res."},{"key":"BFsrep34225_CR17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/liv.12496","volume":"34","author":"Y Chen","year":"2014","unstructured":"Chen, Y. & Verfaillie, C. M. MicroRNAs: the fine modulators of liver development and function. Liver Int. 34, 976\u2013990 (2014).","journal-title":"Liver Int."},{"key":"BFsrep34225_CR18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/toxsci\/kfu232","volume":"143","author":"J Krauskopf","year":"2015","unstructured":"Krauskopf, J. et al. Application of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury. Toxicol. Sci. 143, 268\u2013276 (2015).","journal-title":"Toxicol. Sci."},{"key":"BFsrep34225_CR19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1021\/tx2003799","volume":"25","author":"D Lizarraga","year":"2012","unstructured":"Lizarraga, D. et al. Benzo[a]pyrene-induced changes in microRNA-mRNA networks. Chem. Res. Toxicol. 25, 838\u2013849 (2012).","journal-title":"Chem. Res. Toxicol."},{"key":"BFsrep34225_CR20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tox.2011.04.011","volume":"285","author":"S Halappanavar","year":"2011","unstructured":"Halappanavar, S. et al. Pulmonary gene and microRNA expression changes in mice exposed to benzo(a)pyrene by oral gavage. Toxicology 285, 133\u2013141 (2011).","journal-title":"Toxicology"},{"key":"BFsrep34225_CR21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fphar.2015.00236","volume":"6","author":"J Zheng","year":"2015","unstructured":"Zheng, J. et al. Integrated expression profiles of mRNA and microRNA in the liver of Fructus Meliae Toosendan water extract injured mice. Front. Pharmacol. 6, 236 (2015).","journal-title":"Front. Pharmacol."},{"key":"BFsrep34225_CR22","doi-asserted-by":"crossref","first-page":"81774","DOI":"10.1039\/C5RA10112C","volume":"5","author":"C Ji","year":"2015","unstructured":"Ji, C. et al. Revealing the mechanism of Fructus meliae toosendan-induced liver injury in mice by integrating microRNA and mRNA-based toxicogenomics data. Rsc Adv. 5, 81774\u201381783 (2015).","journal-title":"Rsc Adv."},{"key":"BFsrep34225_CR23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1021\/tx200168d","volume":"24","author":"AF Stepan","year":"2011","unstructured":"Stepan, A. F. et al. Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem. Res. Toxicol. 24, 1345\u20131410 (2011).","journal-title":"Chem. Res. Toxicol."},{"key":"BFsrep34225_CR24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1021\/tx060143k","volume":"19","author":"A Druckova","year":"2006","unstructured":"Druckova, A. & Marnett, L. J. Characterization of the amino acid adducts of the enedial derivative of teucrin A. Chem. Res. Toxicol. 19, 1330\u20131340 (2006).","journal-title":"Chem. Res. Toxicol."},{"key":"BFsrep34225_CR25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1021\/tx7001405","volume":"20","author":"A Druckova","year":"2007","unstructured":"Druckova, A., Mernaugh, R. L., Ham, A. J. & Marnett, L. J. Identification of the protein targets of the reactive metabolite of teucrin A in vivo in the rat. Chem. Res. Toxicol. 20, 1393\u20131408 (2007).","journal-title":"Chem. Res. Toxicol."},{"key":"BFsrep34225_CR26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1021\/tx0496993","volume":"18","author":"BR Baer","year":"2005","unstructured":"Baer, B. R., Rettie, A. E. & Henne, K. R. Bioactivation of 4-ipomeanol by CYP4B1: adduct characterization and evidence for an enedial intermediate. Chem. Res. Toxicol. 18, 855\u2013864 (2005).","journal-title":"Chem. Res. Toxicol."},{"key":"BFsrep34225_CR27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00984100290071216","volume":"65","author":"TR Van Vleet","year":"2002","unstructured":"Van Vleet, T. R., Klein, P. J. & Coulombe, R. A. Jr. Metabolism and cytotoxicity of aflatoxin b1 in cytochrome p-450-expressing human lung cells. J. Toxicol. Environ. Health A 65, 853\u2013867 (2002).","journal-title":"J. Toxicol. Environ. Health A"},{"key":"BFsrep34225_CR28","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/tx5002145","volume":"27","author":"J Yu","year":"2014","unstructured":"Yu, J., Deng, P., Zhong, D. & Chen, X. Identification of amino acid and glutathione N-conjugates of toosendanin: bioactivation of the furan ring mediated by CYP3A4. Chem. Res. Toxicol. 27, 1598\u20131609 (2014).","journal-title":"Chem. Res. Toxicol."},{"key":"BFsrep34225_CR29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.taap.2009.08.018","volume":"244","author":"Q Zhang","year":"2010","unstructured":"Zhang, Q., Pi, J., Woods, C. G. & Andersen, M. E. A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol. Applied Pharmacol. 244, 84\u201397 (2010).","journal-title":"Toxicol. Applied Pharmacol."},{"key":"BFsrep34225_CR30","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2010.11.006","volume":"54","author":"K Begriche","year":"2011","unstructured":"Begriche, K., Massart, J., Robin, M. A., Borgne-Sanchez, A. & Fromenty, B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J. Hepatol. 54, 773\u2013794 (2011).","journal-title":"J. Hepatol."},{"key":"BFsrep34225_CR31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1152\/physiolgenomics.00127.2009","volume":"41","author":"LM Sanderson","year":"2010","unstructured":"Sanderson, L. M., Boekschoten, M. V., Desvergne, B., Muller, M. & Kersten, S. Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta\/delta in regulation of gene expression in mouse liver. Physiol. Genomics 41, 42\u201352 (2010).","journal-title":"Physiol. Genomics"},{"key":"BFsrep34225_CR32","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1161\/ATVBAHA.113.301948","volume":"33","author":"MA VerHague","year":"2013","unstructured":"VerHague, M. A., Cheng, D., Weinberg, R. B. & Shelness, G. S. Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler. Thromb. Vasc. Biol. 33, 2501\u20132508 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFsrep34225_CR33","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s10620-011-1599-9","volume":"56","author":"C Xu","year":"2011","unstructured":"Xu, C. et al. Correlation analysis between gene expression profile of rat liver tissues and high-fat emulsion-induced nonalcoholic fatty liver. Dig. Dis. Sci. 56, 2299\u20132308 (2011).","journal-title":"Dig. Dis. Sci."},{"key":"BFsrep34225_CR34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbrc.2011.05.127","volume":"410","author":"MS Abdel-Bakky","year":"2011","unstructured":"Abdel-Bakky, M. S., Hammad, M. A., Walker, L. A. & Ashfaq, M. K. Tissue factor dependent liver injury causes release of retinoid receptors (RXR-alpha and RAR-alpha) as lipid droplets. Biochem. Biophys. Res. Commun. 410, 146\u2013151 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFsrep34225_CR35","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.fct.2013.01.020","volume":"55","author":"X Lu","year":"2013","unstructured":"Lu, X. et al. Integrated analysis of transcriptomics and metabonomics profiles in aflatoxin B1-induced hepatotoxicity in rat. Food Chem. Toxicol. 55, 444\u2013455 (2013).","journal-title":"Food Chem. Toxicol."},{"key":"BFsrep34225_CR36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/toxsci\/kfu124","volume":"141","author":"S Rudraiah","year":"2014","unstructured":"Rudraiah, S. et al. Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes. Toxicol. Sci. 141, 263\u2013277 (2014).","journal-title":"Toxicol. Sci."},{"key":"BFsrep34225_CR37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.taap.2013.09.025","volume":"274","author":"MA O\u2019Connor","year":"2014","unstructured":"O\u2019Connor, M. A. et al. Analysis of changes in hepatic gene expression in a murine model of tolerance to acetaminophen hepatotoxicity (autoprotection). Toxicol. Appl. Pharmacol. 274, 156\u2013167 (2014).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"BFsrep34225_CR38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/019262339101900106","volume":"19","author":"KN Thakore","year":"1991","unstructured":"Thakore, K. N. & Mehendale, H. M. Role of hepatocellular regeneration in CCl4 autoprotection. Toxicol. Pathol. 19, 47\u201358 (1991).","journal-title":"Toxicol. Pathol."},{"key":"BFsrep34225_CR39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/liv.12988","volume":"36","author":"L Dara","year":"2016","unstructured":"Dara, L., Liu, Z. X. & Kaplowitz, N. Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications. Liver Int. 36, 158\u2013165 (2016).","journal-title":"Liver Int."},{"key":"BFsrep34225_CR40","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.ajpath.2014.07.019","volume":"184","author":"B Bhushan","year":"2014","unstructured":"Bhushan, B. et al. Pro-regenerative signaling after acetaminophen-induced acute liver injury in mice identified using a novel incremental dose model. Am. J. Pathol. 184, 3013\u20133025 (2014).","journal-title":"Am. J. Pathol."},{"key":"BFsrep34225_CR41","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1478-3231.2011.02542.x","volume":"31","author":"B Delgado-Coello","year":"2011","unstructured":"Delgado-Coello, B., Briones-Orta, M. A., Macias-Silva, M. & Mas-Oliva, J. Cholesterol: recapitulation of its active role during liver regeneration. Liver Int. 31, 1271\u20131284 (2011).","journal-title":"Liver Int."},{"key":"BFsrep34225_CR42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrm2336","volume":"9","author":"E Ikonen","year":"2008","unstructured":"Ikonen, E. Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 9, 125\u2013138 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFsrep34225_CR43","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22354","volume":"48","author":"A Zaid","year":"2008","unstructured":"Zaid, A. et al. Proprotein convertase subtilisin\/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration. Hepatology 48, 646\u2013654 (2008).","journal-title":"Hepatology"},{"key":"BFsrep34225_CR44","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.23436","volume":"51","author":"G Lo Sasso","year":"2010","unstructured":"Lo Sasso, G. et al. Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes. Hepatology 51, 1334\u20131344 (2010).","journal-title":"Hepatology"},{"key":"BFsrep34225_CR45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/mol.106.023465","volume":"70","author":"KA Mitchell","year":"2006","unstructured":"Mitchell, K. A., Lockhart, C. A., Huang, G. & Elferink, C. J. Sustained aryl hydrocarbon receptor activity attenuates liver regeneration. Mol. Pharmacol. 70, 163\u2013170 (2006).","journal-title":"Mol. Pharmacol."},{"key":"BFsrep34225_CR46","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1124\/dmd.108.023457","volume":"36","author":"T Celius","year":"2008","unstructured":"Celius, T. et al. Aryl hydrocarbon receptor-dependent induction of flavin-containing monooxygenase mRNAs in mouse liver. Drug Metab. Dispos. 36, 2499\u20132505 (2008).","journal-title":"Drug Metab. Dispos."},{"key":"BFsrep34225_CR47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.taap.2010.05.018","volume":"247","author":"T Celius","year":"2010","unstructured":"Celius, T. et al. Flavin-containing monooxygenase-3: induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver. Toxicol. Appl. Pharmacol. 247, 60\u201369 (2010).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"BFsrep34225_CR48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1053\/jhep.2002.34942","volume":"36","author":"Y Inoue","year":"2002","unstructured":"Inoue, Y. et al. p53 May positively regulate hepatocyte proliferation in rats. Hepatology 36, 336\u2013344 (2002).","journal-title":"Hepatology"},{"key":"BFsrep34225_CR49","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1124\/dmd.114.059394","volume":"42","author":"X Fan","year":"2014","unstructured":"Fan, X. et al. Dynamic and coordinated regulation of KEAP1-NRF2-ARE and p53\/p21 signaling pathways is associated with acetaminophen injury responsive liver regeneration. Drug Metab. Dispos. 42, 1532\u20131539 (2014).","journal-title":"Drug Metab. Dispos."},{"key":"BFsrep34225_CR50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/17512433.2013.841078","volume":"6","author":"N Ding","year":"2013","unstructured":"Ding, N., Liddle, C., Evans, R. M. & Downes, M. Hepatic actions of vitamin D receptor ligands: a sunshine option for chronic liver disease? Expert Rev. Clin. Pharmacol. 6, 597\u2013599 (2013).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"BFsrep34225_CR51","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajpath.2014.12.020","volume":"185","author":"W Chen","year":"2015","unstructured":"Chen, W. et al. Deletion of Mir155 prevents Fas-induced liver injury through up-regulation of Mcl-1. Am. J. Pathol. 185, 1033\u20131044 (2015).","journal-title":"Am. J. Pathol."},{"key":"BFsrep34225_CR52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20071944","volume":"205","author":"P Aliahmad","year":"2008","unstructured":"Aliahmad, P. & Kaye, J. Development of all CD4 T lineages requires nuclear factor TOX. J. Exp. Med. 205, 245\u2013256 (2008).","journal-title":"J. Exp. Med."},{"key":"BFsrep34225_CR53","first-page":"469","volume":"11","author":"M Hu","year":"1991","unstructured":"Hu, M. We must be careful of using toosendanin as an ascarifuge. Zhonguo Yi Yuan Yao Xue Za Zhi 11, 469 Chinese (1991).","journal-title":"Zhonguo Yi Yuan Yao Xue Za Zhi"},{"key":"BFsrep34225_CR54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J Basic Clin. Pharm. 7, 27\u201331 (2016).","journal-title":"J Basic Clin. Pharm."},{"key":"BFsrep34225_CR55","doi-asserted-by":"crossref","first-page":"015106","DOI":"10.1088\/0957-4484\/24\/1\/015106","volume":"24","author":"X Lu","year":"2013","unstructured":"Lu, X. et al. Toxicogenomic analysis of the particle dose- and size-response relationship of silica particles-induced toxicity in mice. Nanotechnology 24, 015106 (2013).","journal-title":"Nanotechnology"},{"key":"BFsrep34225_CR56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1261\/rna.234507","volume":"13","author":"H Wang","year":"2007","unstructured":"Wang, H., Ach, R. A. & Curry, B. Direct and sensitive miRNA profiling from low-input total RNA. RNA 13, 151\u2013159 (2007).","journal-title":"RNA"},{"key":"BFsrep34225_CR57","unstructured":"Parman, C. & Halling, C. AffyQCReport: A Package to Generate QC Reports for Affymetrix Array Data. Available at: https:\/\/www.bioconductor.org\/packages\/devel\/bioc\/vignettes\/affyQCReport\/inst\/doc\/affyQCReport.pdf (2016)."},{"key":"BFsrep34225_CR58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1471-2164-12-64","volume":"12","author":"P Lopez-Romero","year":"2011","unstructured":"Lopez-Romero, P. Pre-processing and differential expression analysis of Agilent microRNA arrays using the AgiMicroRna Bioconductor library. BMC Genomics 12, 64 (2011).","journal-title":"BMC Genomics"},{"key":"BFsrep34225_CR59","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","volume":"466","author":"H Guo","year":"2010","unstructured":"Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835\u2013840 (2010).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep34225","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T22:17:47Z","timestamp":1672870667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep34225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,5]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,14]]}},"alternative-id":["BFsrep34225"],"URL":"https:\/\/doi.org\/10.1038\/srep34225","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,5]]},"assertion":[{"value":"28 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34225"}}